Householder Group Estate & Retirement Specialist LLC Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Householder Group Estate & Retirement Specialist LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 92.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 159 shares of the healthcare conglomerate’s stock after selling 2,042 shares during the period. Householder Group Estate & Retirement Specialist LLC’s holdings in UnitedHealth Group were worth $80,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Chemistry Wealth Management LLC lifted its position in UnitedHealth Group by 0.8% in the 4th quarter. Chemistry Wealth Management LLC now owns 7,609 shares of the healthcare conglomerate’s stock valued at $3,849,000 after acquiring an additional 61 shares in the last quarter. CNB Bank lifted its position in UnitedHealth Group by 3.7% in the 4th quarter. CNB Bank now owns 4,870 shares of the healthcare conglomerate’s stock valued at $2,464,000 after acquiring an additional 173 shares in the last quarter. Saxon Interests Inc. lifted its position in UnitedHealth Group by 49.4% in the 4th quarter. Saxon Interests Inc. now owns 3,437 shares of the healthcare conglomerate’s stock valued at $1,738,000 after acquiring an additional 1,136 shares in the last quarter. Avanza Fonder AB bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $40,861,000. Finally, Procyon Advisors LLC lifted its holdings in shares of UnitedHealth Group by 13.3% during the 4th quarter. Procyon Advisors LLC now owns 23,701 shares of the healthcare conglomerate’s stock valued at $11,989,000 after buying an additional 2,780 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

Shares of UnitedHealth Group stock opened at $510.03 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a 50-day moving average price of $549.37 and a 200-day moving average price of $562.73. The firm has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on UNH shares. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.